CIK 0001706431
- Large accelerated filer
Vir Biotechnology, Inc.
Sign in to watch- Ticker
- VIR
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 812730369
- Phone
- +1 415-906-4324
- Business address
- 1800 OWENS STREET, SUITE 900, SAN FRANCISCO, CA, 94158
- 4 Open-market sale Director sold 15,173 shares at $37.39 ($567,385)
- 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $35.10 ($48,263)
- 4 Open-market sale Chief Medical Officer sold 5,000 shares at an average $37.19 ($185,956)
- 4 Open-market sale EVP, Research & CSO sold 1,375 shares at $39.95 ($54,931)
- 4 Other disposition Director disposed of 1,750,000 shares (other)
- 4 Other disposition 10% owner disposed of 1,750,000 shares (other)
- 4 Open-market sale 10% owner sold 400,022 shares at $52.73 ($21,093,160)
- 4 Open-market sale Director sold 15,174 shares at an average $54.53 ($827,485)
- 4 Open-market sale Chief Medical Officer sold 5,000 shares at an average $50.72 ($253,608)
- 4 Open-market sale EVP, Research & CSO sold 4,125 shares at an average $48.63 ($200,585)
- 4 Open-market sale Chief Medical Officer sold 7,500 shares at an average $43.45 ($325,841)
- 4 Open-market sale EVP, Research & CSO sold 15,125 shares at an average $49.60 ($750,200)
- 4 Open-market sale Chief Administrative Officer sold 10,000 shares at $50.00 ($500,000)
- 4 Open-market sale Director sold 1,435 shares at $46.25 ($66,369)
- 4 Open-market buy Chief Technology Officer bought 11.52 shares at $43.39 ($500)
- 4 Other disposition Director disposed of 500,000 shares (other)
- 4 Other disposition 10% owner disposed of 500,000 shares (other)
- 4 Open-market sale Director sold 15,174 shares at $36.80 ($558,403)
- 4 Other disposition Director disposed of 500,000 shares (other)
- 4 Other disposition 10% owner disposed of 500,000 shares (other)
Page 14 of 25 · 491 filings